Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for making central nervous system agents that are TRPV1 antagonists

Methods for making central nervous system agents that are TRPV1 antagonists

US Patent 8232411 · Granted Jul 31, 2012

Estimated economic value: $42,316,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant p-hydroxyphenylpyruvate dioxygenase, and coding nucleic acid and use ther2025
Reusable SERS molecule detection apparatus and use method thereof2025
Nucleic acid extraction composition, reagent and kit containing the same and use2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
Kappa opioid receptor peptide amide ligands2025
Method of treating cancer using a combination of entinostat and an anti-CSF-1R a2024
Selection of patients for combination therapy2024
Covalent peptide binders2024
Anti-PD-1 antibodies2023
Channeled fibers in separation of biologically active nanoparticles2023
Amino alcohol derivative, pharmaceutical composition and application thereof2023
Multifunctional protein2022